To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CSE1LTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
569 supporting clones for gene CSE1L back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DC402796 testis .a 1 to 561 1 to 562   tiling clone,   562/562
(100 %)
1 diff
(99.9 %id)
DC402014 testis .a 17 to 587 1 to 571       571/571
(100 %)
0 diff
(100 %id)
DC361974 Kidney .a 19 to 576 1 to 558       558/558
(100 %)
1 diff
(99.9 %id)
DC401529 testis .a 22 to 575 1 to 554       554/554
(100 %)
0 diff
(100 %id)
DC401892 testis .a 22 to 586 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
DC403741 testis .a 51 to 493 1 to 447       447/447
(100 %)
6 diff
(98.7 %id)
DC403702 testis .a 53 to 590 1 to 538       538/538
(100 %)
1 diff
(99.9 %id)
DC423351 uterus .a 53 to 574 1 to 522       522/522
(100 %)
2 diff
(99.7 %id)
DA123040 cerebellum .a 54 to 611 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DC307416 cerebellum .a 55 to 594 1 to 540       540/540
(100 %)
0 diff
(100 %id)
DC309863 cerebellum .a 55 to 590 1 to 537       535/537
(99 %)
1 diff
(99.9 %id)
DC400806 testis .a 55 to 590 1 to 536       536/536
(100 %)
0 diff
(100 %id)
DC400997 testis .a 55 to 592 1 to 538       538/538
(100 %)
1 diff
(99.9 %id)
DC401354 testis .a 55 to 592 1 to 539       537/539
(99 %)
2 diff
(99.7 %id)
DC403460 testis .a 55 to 535 1 to 481       481/481
(100 %)
0 diff
(100 %id)
DC404250 testis .a 55 to 542 1 to 488       488/488
(100 %)
0 diff
(100 %id)
DC404544 testis .a 55 to 574 1 to 520       520/520
(100 %)
0 diff
(100 %id)
DC418144 trachea .a 55 to 509 1 to 456       454/456
(99 %)
2 diff
(99.6 %id)
DA954314 Spleen .a 56 to 631 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DC401013 testis .a 57 to 590 1 to 534       534/534
(100 %)
2 diff
(99.7 %id)
DC401319 testis .a 57 to 583 1 to 527       527/527
(100 %)
2 diff
(99.7 %id)
DC401325 testis .a 57 to 588 1 to 533       531/533
(99 %)
2 diff
(99.7 %id)
DA298447 hippocampus .a 58 to 633 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DC320659 brain .a 59 to 472 1 to 414       414/414
(100 %)
0 diff
(100 %id)
DB471979 hippocampus .a 59 to 704 1 to 647       647/650
(99 %)
3 diff
(99.6 %id)
DC401165 testis .a 59 to 584 1 to 526       526/526
(100 %)
1 diff
(99.9 %id)
DC402246 testis .a 59 to 517 1 to 461       461/461
(100 %)
2 diff
(99.6 %id)
DA106978 cerebellum .a 60 to 640 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA332588 hippocampus .a 60 to 635 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DB090599 testis .a 60 to 633 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DC401014 testis .a 63 to 589 1 to 527       527/527
(100 %)
0 diff
(100 %id)
TI_44349363   .a 66 to 864 87 to 888       800/1133
(70 %)
28 diff
(97.6 %id)
BC108309 Testis, embryonal carcinoma .a 71 to 3269 1 to 3199 exact AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 3199/3199
(100 %)
1 diff
(100.0 %id)
NM_001316.2   .a 72 to 3630 1 to 3559 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 3559/3559
(100 %)
0 diff
(100 %id)
DA041854 bladder .a 75 to 648 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DB155361 thymus .a 75 to 656 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
TI_44348027   .a 78 to 818 84 to 824       741/825
(89 %)
11 diff
(98.7 %id)
AF053641 brain; spinal cord; peripheral nerves .a 83 to 3630 1 to 3549 F231W D233G E514G G898X tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 3549/3549
(100 %)
7 diff
(99.9 %id)
TI_45211626   .a 83 to 881 92 to 893       802/1230
(65 %)
22 diff
(98.3 %id)
U33286 placenta .a 83 to 3229 1 to 3147 F231W D233G E514G K848N K934M     3147/3147
(100 %)
9 diff
(99.8 %id)
DA388775 thalamus .a 84 to 674 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
AU130354   .a 84 to 929 2 to 845   capped   844/844
(100 %)
6 diff
(99.3 %id)
AK312306 cerebellum .a 86 to 3121 1 to 3036 exact     3036/3036
(100 %)
3 diff
(100.0 %id)
AL518282 brain, neuroblastoma, neuroblastoma cells .a 86 to 1194 1 to 1103       1103/1106
(99 %)
8 diff
(99.3 %id)
DA242199 brain .a 87 to 679 2 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
DA299847 hippocampus .a 87 to 673 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
DA446342 tongue, tumor tissue .a 87 to 660 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA457842 tongue, tumor tissue .a 87 to 660 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA497739 brain .a 87 to 660 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BY796104 eye .a 87 to 703 1 to 617       617/617
(100 %)
0 diff
(100 %id)
DB238730 trachea .a 87 to 672 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DB162676 thymus .a 88 to 669 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
DA116507 cerebellum .a 91 to 668 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA444833 tongue, tumor tissue .a 91 to 663 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA528436 brain .a 91 to 705 2 to 616   capped   615/615
(100 %)
0 diff
(100 %id)
DA779067 brain .a 91 to 665 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA863564 placenta .a 91 to 752 2 to 664   capped   663/663
(100 %)
1 diff
(99.9 %id)
DC382756 Prostate .a 91 to 967 1 to 871       871/875
(99 %)
9 diff
(99.0 %id)
DB210235 trachea .a 91 to 718 2 to 629   capped   628/628
(100 %)
0 diff
(100 %id)
DB239322 trachea .a 91 to 674 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
DA057798 cerebellum .a 92 to 681 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
DA128616 cerebellum .a 92 to 672 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA165678 amygdala .a 92 to 677 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA218590 brain .a 92 to 760 2 to 670   capped   669/669
(100 %)
0 diff
(100 %id)
DA234165 brain .a 92 to 667 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA235393 brain .a 92 to 662 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA239046 brain .a 92 to 681 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
DA240469 brain .a 92 to 674 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DA241807 brain .a 92 to 686 2 to 596   capped   595/595
(100 %)
0 diff
(100 %id)
DA319336 hippocampus .a 92 to 663 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA333721 hippocampus .a 92 to 687 2 to 597   capped   596/596
(100 %)
0 diff
(100 %id)
DA339214 hippocampus .a 92 to 687 2 to 597   capped   596/596
(100 %)
0 diff
(100 %id)
DA346375 substantia nigra .a 92 to 675 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
DA388873 thalamus .a 92 to 676 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DA395446 thalamus .a 92 to 665 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA459857 tongue, tumor tissue .a 92 to 663 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA488973 brain .a 92 to 676 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DA498220 brain .a 92 to 667 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA528995 brain .a 92 to 688 2 to 598   capped   597/597
(100 %)
0 diff
(100 %id)
DA530109 brain .a 92 to 687 2 to 597   capped   596/596
(100 %)
0 diff
(100 %id)
DA549943   .a 92 to 664 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA581022 lung .a 92 to 831 2 to 743   capped   742/745
(99 %)
8 diff
(99.0 %id)
DA619417   .a 92 to 679 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DA720197   .a 92 to 665 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA750203   .a 92 to 678 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
DA766034 tongue .a 92 to 662 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA798102 brain .a 92 to 667 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA856228 placenta .a 92 to 690 2 to 600   capped   599/599
(100 %)
0 diff
(100 %id)
DA863559 placenta .a 92 to 749 2 to 659   capped   658/658
(100 %)
0 diff
(100 %id)
DA865172 placenta .a 92 to 667 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA905486   .a 92 to 662 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DB046121 testis .a 92 to 665 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DB075576 testis .a 92 to 666 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DB078959 testis .a 92 to 665 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DB080178 testis .a 92 to 669 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DB080670 testis .a 92 to 668 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DB080923 testis .a 92 to 664 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DB080928 testis .a 92 to 668 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DB080961 testis .a 92 to 667 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DB082434 testis .a 92 to 668 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DB082435 testis .a 92 to 665 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DB090622 testis .a 92 to 676 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DB090764 testis .a 92 to 667 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DB094906 testis .a 92 to 674 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DB097831 testis .a 92 to 675 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
DB099173 testis .a 92 to 679 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DB099270 testis .a 92 to 691 2 to 601   capped   600/600
(100 %)
0 diff
(100 %id)
DB100142 testis .a 92 to 672 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DB100619 testis .a 92 to 690 2 to 600   capped   599/599
(100 %)
0 diff
(100 %id)
DB152315 thymus .a 92 to 684 2 to 594   capped   593/598
(99 %)
2 diff
(99.7 %id)
DB152396 thymus .a 92 to 679 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DB153772 thymus .a 92 to 673 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
DB155839 thymus .a 92 to 677 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DB156341 thymus .a 92 to 672 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DB162771 thymus .a 92 to 663 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DB164032 thymus .a 92 to 671 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DB199456 trachea .a 92 to 663 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DB229925 trachea .a 92 to 681 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
DB240595 trachea .a 92 to 679 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DB251986 uterus .a 92 to 670 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DB257306 uterus .a 92 to 665 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA418629 thalamus .a 93 to 747 2 to 656   capped   655/655
(100 %)
0 diff
(100 %id)
DA303208 hippocampus .a 94 to 674 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA406938 thalamus .a 94 to 739 2 to 647   capped   646/646
(100 %)
0 diff
(100 %id)
DB155453 thymus .a 94 to 676 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DB164192 thymus .a 94 to 672 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
CN368177 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 100 to 741 1 to 642       642/642
(100 %)
0 diff
(100 %id)
DB078737 testis .a 100 to 672 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
BC109313 PCR rescued clones .a 104 to 3403 1 to 3300 exact     3300/3300
(100 %)
1 diff
(100.0 %id)
BC109314 PCR rescued clones .a 104 to 3403 1 to 3300 exact tiling clone,   3300/3300
(100 %)
0 diff
(100 %id)
DA388041 thalamus .a 108 to 715 2 to 609   capped   608/608
(100 %)
0 diff
(100 %id)
BJ991154 hepatoblastoma .a 108 to 690 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BM459466 lymph, lymphoma, cell line .a 108 to 782 1 to 678       678/1007
(67 %)
14 diff
(98.7 %id)
DA327971 hippocampus .a 109 to 657 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA472226   .a 109 to 646 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DA496859 brain .a 109 to 684 2 to 577   capped   576/579
(99 %)
3 diff
(99.5 %id)
DA516710 brain .a 109 to 660 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DA559163   .a 109 to 655 2 to 548   capped   547/547
(100 %)
2 diff
(99.7 %id)
BU165492 eye, retinoblastoma .a 109 to 879 1 to 771       771/926
(83 %)
15 diff
(98.4 %id)
BQ932564 leiomyosarcoma, uterus .a 109 to 773 1 to 670       670/973
(68 %)
11 diff
(98.9 %id)
DA606051   .a 109 to 654 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA754706   .a 109 to 655 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA769822 brain .a 109 to 637 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
DA854696 placenta .a 109 to 684 2 to 577   capped   576/582
(98 %)
2 diff
(99.7 %id)
DB092358 testis .a 109 to 648 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
DB095053 testis .a 109 to 701 2 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
DB095897 testis .a 109 to 668 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DB229067 trachea .a 109 to 710 2 to 603   capped   602/602
(100 %)
0 diff
(100 %id)
DB237589 trachea .a 109 to 665 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
AA317882 retina .a 110 to 553 1 to 447       447/447
(100 %)
5 diff
(98.9 %id)
BG392101 embryonal carcinoma, cell line, testis .a 110 to 746 1 to 639       639/639
(100 %)
5 diff
(99.3 %id)
DA454443 tongue, tumor tissue .a 111 to 705 2 to 596   capped   595/595
(100 %)
0 diff
(100 %id)
BM470615 leiomyosarcoma, uterus .a 111 to 974 1 to 864       864/1007
(85 %)
2 diff
(99.9 %id)
CD243923 testis .a 111 to 877 1 to 770       770/836
(92 %)
11 diff
(98.7 %id)
CD244308 testis .a 111 to 879 1 to 771       771/802
(96 %)
7 diff
(99.2 %id)
DA644941   .a 111 to 706 2 to 597   capped   596/598
(99 %)
1 diff
(99.9 %id)
DA862792 placenta .a 111 to 675 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB014261 esophageal, tumor tissue .a 111 to 674 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DB081364 testis .a 111 to 648 2 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
DB086648 testis .a 111 to 681 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DB132012 thymus .a 111 to 672 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DB137640 thymus .a 111 to 662 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DB232045 trachea .a 111 to 701 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
BQ221808 embryonal carcinoma, cell line, testis .a 112 to 971 1 to 861       861/861
(100 %)
3 diff
(99.7 %id)
BQ946240 leiomyosarcoma, uterus .a 112 to 996 1 to 889       889/889
(100 %)
11 diff
(98.8 %id)
CN368184 embryonic stem cells, cell lines H1, H7, andH9 .a 113 to 768 1 to 656       656/656
(100 %)
1 diff
(99.9 %id)
BI088396 cervix .a 114 to 773 1 to 664       662/1048
(63 %)
12 diff
(98.9 %id)
TI_154147521   .a 114 to 881 80 to 848       769/842
(91 %)
38 diff
(95.5 %id)
BU195497 melanotic melanoma, skin .a 117 to 919 1 to 811       811/818
(99 %)
14 diff
(98.3 %id)
DB483925 hippocampus .a 118 to 623 1 to 506       506/506
(100 %)
0 diff
(100 %id)
CN368167 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 120 to 772 1 to 653       653/653
(100 %)
0 diff
(100 %id)
AA307378 colon .a 121 to 511 1 to 395       395/395
(100 %)
4 diff
(99.0 %id)
CV570069 cornea, eye .a 122 to 718 1 to 597       597/597
(100 %)
0 diff
(100 %id)
CN368188 embryonic stem cells, cell lines H1, H7, andH9 .a 123 to 909 1 to 787       787/787
(100 %)
2 diff
(99.8 %id)
CN368185 embryonic stem cells, DMSO-treated H9 cellline .a 125 to 647 9 to 531       523/531
(98 %)
6 diff
(98.9 %id)
T10722   .a 125 to 339 1 to 215     Submitted on the opposite strand 215/215
(100 %)
2 diff
(99.1 %id)
BU521521 leiomyosarcoma, uterus .a 132 to 969 1 to 844       844/900
(93 %)
8 diff
(99.2 %id)
AA207207   .a 133 to 610 1 to 478       478/478
(100 %)
1 diff
(99.8 %id)
AA315560 colon .a 134 to 333 1 to 201       201/201
(100 %)
1 diff
(99.6 %id)
CN368180 embryonic stem cells, cell lines H1, H7, andH9 .a 134 to 616 1 to 483       483/483
(100 %)
0 diff
(100 %id)
BF928815 nervous_tumor .a 139 to 402 1 to 264       264/264
(100 %)
6 diff
(97.8 %id)
DA460534 tongue, tumor tissue .a 139 to 713 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
BG389666 embryonal carcinoma, cell line, testis .a 139 to 864 1 to 723   AAA   723/1083
(66 %)
12 diff
(98.9 %id)
BM803592 leiomyosarcoma, uterus .a 147 to 855 1 to 709       709/715
(99 %)
2 diff
(99.8 %id)
CN368163 embryonic stem cells, cell lines H1, H7, andH9 .a 149 to 823 1 to 675       675/675
(100 %)
0 diff
(100 %id)
CN368186 embryonic stem cells, cell lines H1, H7, andH9 .a 149 to 814 1 to 666       666/666
(100 %)
0 diff
(100 %id)
CN368182 embryonic stem cells, cell lines H1, H7, andH9 .a 150 to 859 1 to 710       710/710
(100 %)
0 diff
(100 %id)
CN368187 embryonic stem cells, cell lines H1, H7, andH9 .a 150 to 897 1 to 748       748/749
(99 %)
4 diff
(99.5 %id)
CN368172 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 155 to 681 1 to 527       527/527
(100 %)
0 diff
(100 %id)
CN368189 embryonic stem cells, cell lines H1, H7, andH9 .a 161 to 527 1 to 367       367/367
(100 %)
1 diff
(99.8 %id)
CN368176 embryonic stem cells, cell lines H1, H7, andH9 .a 162 to 506 1 to 345       345/345
(100 %)
2 diff
(99.5 %id)
DA800344 brain .a 179 to 687 2 to 510   capped   509/509
(100 %)
0 diff
(100 %id)
DB072720 testis .a 185 to 716 2 to 534   capped   533/533
(100 %)
1 diff
(99.9 %id)
DA505058 brain .a 189 to 719 2 to 533   capped   532/532
(100 %)
1 diff
(99.9 %id)
DN914712   .a 190 to 790 1 to 600       600/614
(97 %)
3 diff
(99.6 %id)
DN914713   .a 190 to 773 594 to 11       584/594
(98 %)
0 diff
(100 %id)
DN914923   .a 190 to 773 1 to 584       584/640
(91 %)
1 diff
(99.9 %id)
AW386316 pnet .a 226 to 772 1 to 547       547/547
(100 %)
4 diff
(99.3 %id)
DA644634   .a 247 to 709 2 to 465   capped   464/464
(100 %)
2 diff
(99.6 %id)
L44546   .a 272 to 661 390 to 1       390/391
(99 %)
5 diff
(98.8 %id)
TI_57228254   .a 274 to 987 55 to 769       715/716
(99 %)
5 diff
(99.4 %id)
DN914924   .a 283 to 773 516 to 26       491/516
(95 %)
0 diff
(100 %id)
DA247748 brain .a 293 to 878 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DB161069 thymus .a 304 to 899 2 to 597   capped   596/596
(100 %)
0 diff
(100 %id)
BU521934 leiomyosarcoma, uterus .a 311 to 1133 1 to 827       827/867
(95 %)
9 diff
(99.0 %id)
AW386335 pnet .a 345 to 812 494 to 23       472/494
(95 %)
17 diff
(96.6 %id)
AA243317 brain, neuroepithelial cells .a 350 to 538 1 to 189       189/189
(100 %)
0 diff
(100 %id)
FN132079 breast carcinoma .a 358 to 438 1 to 84       84/85
(98 %)
7 diff
(91.8 %id)
DA782819 brain .a 384 to 964 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
BF993297 placenta_normal .a 391 to 684 344 to 49       298/344
(86 %)
5 diff
(98.6 %id)
BM456068 lymph, lymphoma, cell line .a 426 to 1337 12 to 926       915/932
(98 %)
15 diff
(98.4 %id)
CD654468 Embryonic Stem cells .a 426 to 1144 12 to 729       718/796
(90 %)
2 diff
(99.8 %id)
DA586128 lung .a 441 to 1022 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
CD299959 testis .a 453 to 1186 1 to 739       739/903
(81 %)
10 diff
(98.9 %id)
DA816507   .a 459 to 1032 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DN914799   .a 473 to 684 222 to 11       212/222
(95 %)
3 diff
(98.7 %id)
BU166372 melanotic melanoma, skin .a 569 to 1328 1 to 768       766/842
(90 %)
14 diff
(98.4 %id)
BM802705 embryonal carcinoma, cell line, testis .a 609 to 1540 1 to 936       936/1126
(83 %)
12 diff
(99.0 %id)
DA444887 tongue, tumor tissue .a 675 to 1262 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
BM452947 melanotic melanoma, skin .a 688 to 1499 1 to 816       816/926
(88 %)
8 diff
(99.2 %id)
EH340244   .a 689 to 765 1 to 77       77/77
(100 %)
0 diff
(100 %id)
DA070670 cerebellum .a 765 to 1315 2 to 552   capped   551/551
(100 %)
3 diff
(99.5 %id)
BE300737 carcinoma cell line, cervix .a 783 to 1396 1 to 614     Submitted on the opposite strand 614/614
(100 %)
1 diff
(99.9 %id)
EH307448   .a 802 to 894 1 to 92       92/92
(100 %)
1 diff
(99.0 %id)
BQ213289 embryonal carcinoma, cell line, testis .a 824 to 1688 1 to 872       872/913
(95 %)
8 diff
(99.2 %id)
BU177239 melanotic melanoma, skin .a 828 to 1540 1 to 714       714/908
(78 %)
8 diff
(99.2 %id)
DA503605 brain .a 833 to 1413 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
BP227777   .a 886 to 1466 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BP230529 brain .a 924 to 1505 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA160417 amygdala .a 934 to 1522 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
DA441215 tongue, tumor tissue .a 944 to 1540 2 to 598   capped   597/597
(100 %)
0 diff
(100 %id)
BP265955 thyroid .a 946 to 1528 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BG256322 embryonal carcinoma, cell line, testis .a 970 to 1547 94 to 673       578/685
(84 %)
22 diff
(96.8 %id)
BM832586 stomach .a 970 to 1373 21 to 424       404/424
(95 %)
6 diff
(98.6 %id)
BM788362 stomach .a 974 to 1667 2 to 695       694/695
(99 %)
0 diff
(100 %id)
BM832993 stomach .a 1001 to 1643 1 to 643       643/643
(100 %)
0 diff
(100 %id)
BM828436 stomach .a 1009 to 1625 1 to 617       617/625
(98 %)
0 diff
(100 %id)
BJ996732 hepatoblastoma .a 1013 to 1455 1 to 443       443/443
(100 %)
0 diff
(100 %id)
DA005617   .a 1032 to 1619 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DA384774 thalamus .a 1049 to 1651 2 to 604   capped   603/603
(100 %)
0 diff
(100 %id)
BX418150 brain, fetal brain .a 1057 to 1904 1 to 848       848/848
(100 %)
5 diff
(99.5 %id)
BX418151 brain, fetal brain .a 1057 to 1689 1 to 633       633/633
(100 %)
0 diff
(100 %id)
BQ440743 melanotic melanoma, skin .a 1058 to 1928 1 to 878       878/880
(99 %)
11 diff
(98.8 %id)
BM453546 leiomyosarcoma, uterus .a 1060 to 1819 1 to 773       773/987
(78 %)
19 diff
(98.1 %id)
CX166763 human embryonic stem cells differentiated toan early endodermal cell type .a 1068 to 1895 1 to 828       828/828
(100 %)
0 diff
(100 %id)
BP373536 umbilical cord .a 1080 to 1660 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DA446457 tongue, tumor tissue .a 1112 to 1702 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
AU280239   .a 1141 to 1712 1 to 572       572/572
(100 %)
0 diff
(100 %id)
BG769933 melanotic melanoma, high MDR (cell line), skin .a 1187 to 2026 1 to 842       842/848
(99 %)
21 diff
(97.6 %id)
BE891547 melanotic melanoma, skin .a 1208 to 1921 1 to 705       705/960
(73 %)
17 diff
(98.3 %id)
AW752491 colon .a 1266 to 1885 623 to 6       618/656
(94 %)
13 diff
(98.1 %id)
CB118931 Liver .a 1269 to 1863 1 to 597       597/597
(100 %)
1 diff
(99.9 %id)
BU184010 melanotic melanoma, skin .a 1276 to 2114 1 to 850       850/890
(95 %)
17 diff
(98.1 %id)
BG767575 melanotic melanoma, high MDR (cell line), skin .a 1286 to 1936 1 to 657       657/661
(99 %)
10 diff
(98.5 %id)
EH314730   .a 1310 to 1380 1 to 71       71/71
(100 %)
0 diff
(100 %id)
BG943589 blood .a 1313 to 1958 1 to 646       646/646
(100 %)
0 diff
(100 %id)
BU182698 melanotic melanoma, skin .a 1331 to 2147 1 to 823       823/844
(97 %)
11 diff
(98.7 %id)
BP251989 Kidney .a 1337 to 1918 1 to 583       583/586
(99 %)
9 diff
(98.5 %id)
BP220509 colon .a 1338 to 1917 1 to 580       580/580
(100 %)
5 diff
(99.2 %id)
BP277484 Kidney .a 1361 to 1913 1 to 553       553/553
(100 %)
0 diff
(100 %id)
AW993922 breast_normal .a 1422 to 2086 671 to 11     Submitted on the opposite strand 661/671
(98 %)
1 diff
(99.9 %id)
BU172602 melanotic melanoma, skin .a 1478 to 2314 1 to 852       852/858
(99 %)
23 diff
(97.4 %id)
BI335239 cervical carcinoma cell line, cervix .a 1490 to 2344 1 to 857       857/857
(100 %)
5 diff
(99.5 %id)
BG284507 adenocarcinoma, cell line, Prostate .a 1493 to 2175 1 to 682       682/692
(98 %)
4 diff
(99.5 %id)
BP206359 coronary artery .a 1517 to 2101 1 to 585       585/585
(100 %)
0 diff
(100 %id)
BP259010 heart .a 1519 to 2098 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BG254914 adenocarcinoma, cell line, Prostate .a 1531 to 2240 1 to 708       708/713
(99 %)
11 diff
(98.5 %id)
BE698915 nervous_normal .a 1571 to 1937 378 to 11       373/378
(98 %)
1 diff
(99.8 %id)
CB140990 Liver .a 1588 to 2217 1 to 630       630/630
(100 %)
0 diff
(100 %id)
BF931761 nervous_tumor .a 1599 to 1985 408 to 21     Submitted on the opposite strand 388/408
(95 %)
4 diff
(99.1 %id)
DR762467 embryonic stem .a 1608 to 2423 1 to 816       816/816
(100 %)
0 diff
(100 %id)
BE003403 breast_normal .a 1621 to 2215 604 to 12     Submitted on the opposite strand 593/607
(97 %)
7 diff
(98.9 %id)
BQ440139 melanotic melanoma, skin .a 1633 to 2386 1 to 757       757/785
(96 %)
3 diff
(99.7 %id)
BQ721070 sympathetic trunk .a 1634 to 2386 1 to 762       762/777
(98 %)
10 diff
(98.8 %id)
BP375883 uterus .a 1646 to 2225 1 to 580       580/580
(100 %)
0 diff
(100 %id)
AU123857   .a 1657 to 2363 2 to 717   capped   716/716
(100 %)
8 diff
(98.9 %id)
BP203719 coronary artery .a 1660 to 2242 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
AU124260   .a 1686 to 2544 2 to 860   capped   859/864
(99 %)
11 diff
(98.8 %id)
BE707116 head_neck .a 1697 to 1880 184 to 1       184/184
(100 %)
0 diff
(100 %id)
BE707117 head_neck .a 1697 to 1892 205 to 10       196/205
(95 %)
0 diff
(100 %id)
TI_57190151   .a 1709 to 2577 48 to 921       872/901
(96 %)
23 diff
(97.5 %id)
DA906768   .a 1719 to 2304 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
CD611287   .a 1730 to 2258 536 to 6       531/591
(89 %)
8 diff
(98.7 %id)
BG771218 adenocarcinoma, Prostate .a 1730 to 2480 1 to 750       750/781
(96 %)
6 diff
(99.3 %id)
AK098618 testis .a 1737 to 3269 1 to 1533   available from FLJ,   1533/1533
(100 %)
1 diff
(100.0 %id)
DB103535 thymus .a 1768 to 2328 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BQ422964 melanotic melanoma, skin .a 1780 to 2488 1 to 712       712/917
(77 %)
10 diff
(99.0 %id)
BP255567 Kidney .a 1786 to 2367 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DT217244 brain .a 1794 to 2348 1 to 554       554/554
(100 %)
1 diff
(99.9 %id)
CD105243 brain, Pituitary .a 1814 to 2612 1 to 808       806/917
(87 %)
13 diff
(98.6 %id)
BM909133 astrocytoma grade IV, cell line, brain .a 1826 to 2599 874 to 23     Submitted on the opposite strand 797/1065
(74 %)
37 diff
(96.6 %id)
CX785973 human embryonic stem cells .a 1843 to 2659 1 to 817       817/817
(100 %)
0 diff
(100 %id)
TI_57190000   .a 1869 to 2648 53 to 831       779/779
(100 %)
4 diff
(99.5 %id)
CN368196 embryonic stem cells, DMSO-treated H9 cellline .a 1892 to 2670 1 to 780       780/781
(99 %)
3 diff
(99.7 %id)
BM470987 melanotic melanoma, skin .a 1933 to 2922 1 to 989       989/993
(99 %)
25 diff
(97.5 %id)
BM837121 Ascites, stomach .a 1934 to 2570 1 to 637       637/637
(100 %)
0 diff
(100 %id)
BI860857 breast, mammary adenocarcinoma, cell line .a 1947 to 2800 1 to 858       858/895
(95 %)
21 diff
(97.7 %id)
TI_57192347   .a 1947 to 2800 55 to 912       858/895
(95 %)
21 diff
(97.7 %id)
EC514595 Prostate .a 1951 to 2026 108 to 34       75/108
(69 %)
1 diff
(99.1 %id)
BI089716 cervix .a 1955 to 2800 1 to 846       848/1000
(84 %)
19 diff
(98.1 %id)
TI_154179725   .a 1979 to 2832 74 to 921       848/850
(99 %)
11 diff
(98.8 %id)
BQ307508 breast .a 1982 to 2358 375 to 1       375/375
(100 %)
4 diff
(99.0 %id)
BQ318680 colon .a 1982 to 2177 216 to 23       197/224
(87 %)
1 diff
(99.6 %id)
AU123950   .a 1994 to 2797 2 to 805   capped   804/804
(100 %)
2 diff
(99.8 %id)
TI_154176964   .a 2015 to 2488 81 to 554       474/540
(87 %)
8 diff
(98.6 %id)
TI_154162817   .a 2034 to 2712 76 to 762   AAA   687/693
(99 %)
11 diff
(98.5 %id)
BM541816 leiomyosarcoma, uterus .a 2044 to 3032 1 to 992       992/1125
(88 %)
11 diff
(99.1 %id)
BM541358 leiomyosarcoma, uterus .a 2118 to 3188 1 to 1076       1076/1076
(100 %)
37 diff
(96.6 %id)
BU152857 epithelioid carcinoma, Pancreas .a 2119 to 3010 1 to 894       894/894
(100 %)
13 diff
(98.6 %id)
FN094576 breast carcinoma .a 2145 to 2249 104 to 1     Submitted on the opposite strand 104/107
(97 %)
1 diff
(99.1 %id)
AL518281 brain, neuroblastoma, neuroblastoma cells .a 2185 to 3238 1050 to 1       1050/1053
(99 %)
11 diff
(99.0 %id)
BM473830 eye, retinoblastoma .a 2193 to 3033 1 to 839       839/988
(84 %)
8 diff
(99.2 %id)
BQ430663 epithelioid carcinoma, Pancreas .a 2222 to 3084 1 to 866       866/866
(100 %)
6 diff
(99.4 %id)
TI_154169221   .a 2228 to 2815 80 to 667       588/588
(100 %)
5 diff
(99.2 %id)
CB147524 Liver .a 2231 to 2864 1 to 634       634/634
(100 %)
0 diff
(100 %id)
CR591648 neuroblastoma .a 2260 to 3271 1 to 1012       1012/1012
(100 %)
0 diff
(100 %id)
AA459503 germinal center B cell .a 2300 to 2830 1 to 531   fully sequenced,   531/531
(100 %)
0 diff
(100 %id)
CR612647 Placenta Cot 25-normalized .a 2301 to 3271 1 to 971       971/971
(100 %)
0 diff
(100 %id)
BF917448 uterus_tumor .a 2327 to 2988 662 to 1     Submitted on the opposite strand 662/662
(100 %)
5 diff
(99.3 %id)
AW813461 stomach .a 2344 to 2850 21 to 531       509/531
(95 %)
26 diff
(95.2 %id)
BF380050 uterus_tumor .a 2346 to 2872 527 to 1       527/527
(100 %)
22 diff
(95.9 %id)
AW609263 stomach .a 2348 to 2855 1 to 510       510/510
(100 %)
39 diff
(92.4 %id)
BG574979 breast, mammary adenocarcinoma, cell line .a 2363 to 3168 1 to 806       806/806
(100 %)
8 diff
(99.1 %id)
H17790 whole brain .a 2374 to 2800 1 to 431     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 431/433
(99 %)
8 diff
(98.2 %id)
BU507290 leiomyosarcoma, uterus .a 2382 to 3033 1 to 653       653/790
(82 %)
2 diff
(99.8 %id)
R16395 whole brain .a 2410 to 2660 1 to 255     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 255/333
(76 %)
8 diff
(97.6 %id)
BF032266 adenocarcinoma, ovary .a 2442 to 3186 1 to 740       740/741
(99 %)
7 diff
(99.1 %id)
BX105965 liver and spleen .a 2455 to 3278 1 to 824       824/824
(100 %)
1 diff
(99.9 %id)
TI_149308506   .a 2457 to 3269 901 to 89   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 813/999
(81 %)
1 diff
(99.9 %id)
AA164768   .a 2475 to 2849 1 to 377       377/377
(100 %)
3 diff
(99.3 %id)
BG211862   .a 2481 to 3285 1 to 805       805/808
(99 %)
35 diff
(95.7 %id)
AI279876 placenta .a 2481 to 3271 798 to 8       791/802
(98 %)
3 diff
(99.7 %id)
BQ233845 epithelioid carcinoma, Pancreas .a 2487 to 3269 830 to 36   AAA Submitted on the opposite strand 795/834
(95 %)
10 diff
(98.9 %id)
TI_159705560   .a 2495 to 3269 857 to 90   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 770/965
(79 %)
20 diff
(98.0 %id)
BM452513 eye, retinoblastoma .a 2503 to 3269 1 to 768   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 768/768
(100 %)
1 diff
(99.9 %id)
TI_149309194   .a 2504 to 3269 854 to 89   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 766/974
(78 %)
2 diff
(99.8 %id)
BM461679 leiomyosarcoma, uterus .a 2506 to 3269 1 to 764       764/770
(99 %)
1 diff
(99.9 %id)
H02142 placenta .a 2508 to 2911 1 to 414   fully sequenced,   414/414
(100 %)
12 diff
(97.2 %id)
BU625136 cell lines, Enchondroma .a 2537 to 3269 751 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 733/733
(100 %)
0 diff
(100 %id)
BQ774762 Bone, Human Chondrosarcoma Cell Line .a 2541 to 3269 739 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 723/721
(100 %)
14 diff
(98.1 %id)
BU687524 lung .a 2558 to 3269 730 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 712/712
(100 %)
1 diff
(99.9 %id)
BU619409 cell lines, Chondrosarcoma .a 2558 to 3269 731 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 713/713
(100 %)
3 diff
(99.6 %id)
AW954410   .a 2559 to 3266 707 to 1     Submitted on the opposite strand 707/741
(95 %)
15 diff
(98.0 %id)
BI964919 Islets of Langerhans, Pancreas .a 2559 to 3142 1 to 583       583/583
(100 %)
10 diff
(98.3 %id)
BX418149 brain, fetal brain .a 2569 to 3527 961 to 9       953/1024
(93 %)
6 diff
(99.5 %id)
AI539769 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 2569 to 3269 730 to 30   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 701/717
(97 %)
7 diff
(99.1 %id)
TI_57186988   .a 2570 to 3367 46 to 840       795/795
(100 %)
16 diff
(98.0 %id)
BI858358 breast, mammary adenocarcinoma, cell line .a 2571 to 3367 1 to 794       794/794
(100 %)
16 diff
(98.0 %id)
CB132433 Liver .a 2572 to 2897 325 to 1     Submitted on the opposite strand 325/341
(95 %)
6 diff
(98.3 %id)
BI964853 Islets of Langerhans, Pancreas .a 2574 to 3062 1 to 489   fully sequenced,   489/489
(100 %)
0 diff
(100 %id)
BF932351 nervous_tumor .a 2581 to 3012 432 to 1     Submitted on the opposite strand 432/432
(100 %)
4 diff
(99.1 %id)
BQ286344 Pancreas, Purified pancreatic islet .a 2585 to 3062 10 to 488   fully sequenced,   479/488
(98 %)
7 diff
(98.6 %id)
BM979705 lung, Primary Lung Epithelial Cells .a 2587 to 3269 701 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 683/683
(100 %)
0 diff
(100 %id)
BG770338 melanotic melanoma, high MDR (cell line), skin .a 2594 to 3271 1 to 680       680/697
(97 %)
7 diff
(99.0 %id)
AW609285 stomach .a 2604 to 3121 524 to 7       518/524
(98 %)
17 diff
(96.8 %id)
AW609271 stomach .a 2607 to 3119 530 to 17       514/530
(96 %)
11 diff
(98.0 %id)
AI963800 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2619 to 3271 659 to 7       653/660
(98 %)
10 diff
(98.5 %id)
BQ774168 Bone, Human Chondrosarcoma Cell Line .a 2627 to 3269 662 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 644/644
(100 %)
3 diff
(99.6 %id)
BE090601 breast .a 2631 to 3017 388 to 1     Submitted on the opposite strand 388/388
(100 %)
10 diff
(97.5 %id)
BF332526 breast .a 2673 to 3001 331 to 1       331/336
(98 %)
20 diff
(94.1 %id)
FN099038 breast carcinoma .a 2708 to 2800 98 to 9     Submitted on the opposite strand 90/98
(91 %)
0 diff
(100 %id)
AU152326   .a 2720 to 3269 551 to 1       551/553
(99 %)
4 diff
(99.3 %id)
BF375100 stomach .a 2722 to 2910 189 to 1       189/189
(100 %)
4 diff
(97.9 %id)
BF369333 placenta_normal .a 2765 to 3005 243 to 4       240/243
(98 %)
0 diff
(100 %id)
DC426471 Prostate .a 2779 to 3279 503 to 1       503/503
(100 %)
9 diff
(98.3 %id)
AA459274 germinal center B cell .a 2784 to 3271 488 to 1   fully sequenced,   488/488
(100 %)
0 diff
(100 %id)
AA164700   .a 2868 to 3182 315 to 1       315/315
(100 %)
0 diff
(100 %id)
H02038 placenta .a 2881 to 3263 400 to 4   fully sequenced,   395/398
(99 %)
12 diff
(97.0 %id)
H17791 whole brain .a 2916 to 3269 376 to 13   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 364/410
(88 %)
13 diff
(96.9 %id)
AW381550 head_neck .a 2922 to 3025 106 to 2       105/106
(99 %)
0 diff
(100 %id)
R42337 whole brain .a 2925 to 3269 374 to 12   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 361/365
(98 %)
21 diff
(94.3 %id)
BI963197 Islets of Langerhans, Pancreas .a 3001 to 3271 272 to 2   fully sequenced,   271/272
(99 %)
0 diff
(100 %id)
BQ269697 Pancreas, Purified pancreatic islet .a 3001 to 3268 268 to 1   fully sequenced,   268/268
(100 %)
0 diff
(100 %id)
FN093471 breast carcinoma .a 3029 to 3097 1 to 69       69/70
(98 %)
2 diff
(97.2 %id)
BI712760 Pancreas, Purified pancreatic islet .a 3031 to 3269 10 to 248   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 239/248
(96 %)
6 diff
(97.6 %id)
FN069955 breast carcinoma .a 3039 to 3114 74 to 1     Submitted on the opposite strand 74/75
(98 %)
2 diff
(97.4 %id)
FN048350 breast carcinoma .a 3048 to 3114 68 to 1     Submitted on the opposite strand 68/69
(98 %)
1 diff
(98.6 %id)
AA570120 colon .a 3049 to 3116 68 to 1       68/70
(97 %)
0 diff
(100 %id)
FN050604 breast carcinoma .a 3061 to 3165 1 to 105       105/105
(100 %)
0 diff
(100 %id)
AW974353   .a 3084 to 3559 604 to 131   AAA Submitted on the opposite strand 474/474
(100 %)
2 diff
(99.6 %id)
BI712520 Pancreas, Purified pancreatic islet .a 3108 to 3268 161 to 1   fully sequenced, Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 161/161
(100 %)
0 diff
(100 %id)
BX328202   .a 3135 to 3271 1 to 133       133/137
(97 %)
9 diff
(93.5 %id)
AI086182 liver and spleen .a 3218 to 3461 251 to 4       248/251
(98 %)
0 diff
(100 %id)
FN098299 breast carcinoma .a 3241 to 3312 9 to 81       73/82
(89 %)
2 diff
(97.6 %id)
AW969578   .a 3259 to 3564 306 to 1     Submitted on the opposite strand 306/448
(68 %)
8 diff
(98.3 %id)
CR742317 colon .a 3267 to 3565 1 to 299   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 299/299
(100 %)
0 diff
(100 %id)
AI868711 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3280 to 3565 287 to 1       287/287
(100 %)
3 diff
(99.0 %id)
BY999491   .a 3298 to 3560 1 to 263     Submitted on the opposite strand 263/265
(99 %)
1 diff
(99.7 %id)
AA493197 colon .a 3301 to 3565 266 to 2       265/266
(99 %)
0 diff
(100 %id)
BE541166 cervix .a 3316 to 3559 1 to 241   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 241/241
(100 %)
3 diff
(98.8 %id)
AA582354 Kidney, kidney tumor .a 3346 to 3469 135 to 12   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 124/124
(100 %)
0 diff
(100 %id)
BM473543 melanotic melanoma, skin .b 1 to 951 1 to 958   tiling clone, AAA   958/1106
(86 %)
17 diff
(98.5 %id)
AK225610 renal proximal tubule .b 870 to 2995 1 to 2126   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2126/2126
(100 %)
3 diff
(99.9 %id)
DC318817 brain .c 1 to 570 1 to 570   tiling clone,   570/570
(100 %)
12 diff
(97.9 %id)
EF426455   .c 318 to 3066 1 to 2749   tiling clone,   2749/2749
(100 %)
1 diff
(100.0 %id)
BJ992103 hepatoblastoma .c 344 to 885 1 to 543       543/551
(98 %)
2 diff
(99.7 %id)
DA736531   .c 679 to 1483 2 to 809   capped   808/849
(95 %)
9 diff
(99.0 %id)
BJ992104 hepatoblastoma .c 2694 to 3177 484 to 1   tiling clone,   484/484
(100 %)
0 diff
(100 %id)
DB369033   .c 3014 to 3574 563 to 1   tiling clone,   563/563
(100 %)
9 diff
(98.5 %id)
AU141925 thyroid gland .d 1 to 856 2 to 852   tiling clone, capped   851/864
(98 %)
12 diff
(98.7 %id)
AU159355 thyroid gland .d 2570 to 3153 585 to 1   tiling clone,   585/585
(100 %)
12 diff
(98.0 %id)
DC388386 small intestine .e 1 to 581 1 to 581   tiling clone,   581/581
(100 %)
1 diff
(99.9 %id)
AK300589   .e 2 to 2694 11 to 2703 exact tiling clone,   2693/2703
(99 %)
8 diff
(99.8 %id)
DC384407   .e 2 to 566 11 to 575       565/575
(98 %)
7 diff
(98.8 %id)
DC348797   .e 18 to 588 1 to 572       572/572
(100 %)
1 diff
(99.9 %id)
DC363363   .e 18 to 512 1 to 495       495/497
(99 %)
3 diff
(99.4 %id)
BG035409 adenocarcinoma, cell line, Liver .e 73 to 770 1 to 692       694/1013
(68 %)
19 diff
(98.2 %id)
AU129979   .e 231 to 1050 2 to 820   capped   819/820
(99 %)
4 diff
(99.6 %id)
AU152034   .e 2146 to 2694 556 to 1       554/559
(99 %)
11 diff
(98.1 %id)
DB094712 testis .f 1 to 557 2 to 559   tiling clone, capped   556/558
(99 %)
1 diff
(99.9 %id)
DA460900 tongue, tumor tissue .f 37 to 586 8 to 557   tiling clone, capped   550/550
(100 %)
1 diff
(99.9 %id)
DA792307 brain .f 230 to 794 2 to 566   tiling clone, capped   570/570
(100 %)
0 diff
(100 %id)
DB084474 testis .f 230 to 779 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
AF053640 trachea .g 1 to 1916 1 to 1919 exact tiling clone,   1919/1919
(100 %)
10 diff
(99.5 %id)
R84306 liver and spleen .g 13 to 534 10 to 542       533/543
(98 %)
27 diff
(95.1 %id)
N90467 liver and spleen .g 13 to 241 11 to 241       231/241
(95 %)
7 diff
(97.1 %id)
N99830 liver and spleen .g 13 to 443 13 to 449       437/449
(97 %)
10 diff
(97.8 %id)
N70691 liver and spleen .g 611 to 965 367 to 1       367/373
(98 %)
18 diff
(95.2 %id)
R87668 liver and spleen .g 650 to 954 309 to 1       309/337
(91 %)
9 diff
(97.4 %id)
N69204 liver and spleen .g 687 to 965 280 to 1       280/280
(100 %)
1 diff
(99.7 %id)
AU185829 skin .g 1204 to 1894 1 to 696   tiling clone,   696/696
(100 %)
13 diff
(98.2 %id)
BF435601 sciatic nerve .g 1497 to 1958 463 to 1       463/463
(100 %)
5 diff
(99.0 %id)
AW029182 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .g 1500 to 1957 458 to 1   tiling clone,   458/458
(100 %)
0 diff
(100 %id)
AA838767 parathyroid gland, parathyroid tumor .g 1519 to 1958 455 to 16   tiling clone,   440/455
(96 %)
0 diff
(100 %id)
T84903 liver and spleen .h 1 to 403 1 to 418   tiling clone,   418/421
(99 %)
29 diff
(93.2 %id)
AF053642 Liver .h 33 to 1429 1 to 1398 exact tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 1398/1398
(100 %)
1 diff
(100.0 %id)
BM794995 Ascites, stomach .h 230 to 734 1 to 505       505/505
(100 %)
0 diff
(100 %id)
AI568159 lymph node, lymphoma, follicular mixed small and largecell .h 578 to 1069 492 to 1       492/493
(99 %)
1 diff
(99.8 %id)
BX506609 Liver .h 583 to 1088 1 to 515       515/515
(100 %)
11 diff
(97.9 %id)
T91320 liver and spleen .h 600 to 1067 486 to 9       476/489
(97 %)
12 diff
(97.6 %id)
T87388 liver and spleen .h 648 to 1120 1 to 494   fully sequenced,   494/494
(100 %)
19 diff
(96.2 %id)
BF685189 leiomyosarcoma cell line, uterus .h 648 to 1067 1 to 420       420/444
(94 %)
2 diff
(99.6 %id)
H67122 liver and spleen .h 656 to 972 1 to 322     Submitted on the opposite strand 322/415
(77 %)
6 diff
(98.6 %id)
T67084 liver and spleen .h 658 to 1042 1 to 384       384/384
(100 %)
1 diff
(99.8 %id)
H77482 liver and spleen .h 667 to 1083 1 to 420       420/420
(100 %)
7 diff
(98.4 %id)
AW472844 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .h 731 to 1068 338 to 1       338/338
(100 %)
0 diff
(100 %id)
FN173098 breast carcinoma .h 758 to 855 1 to 98       98/98
(100 %)
3 diff
(97.0 %id)
C00668   .h 792 to 1068 1 to 277       277/277
(100 %)
1 diff
(99.7 %id)
T79852 liver and spleen .h 1090 to 1439 362 to 1   fully sequenced,   362/362
(100 %)
8 diff
(97.8 %id)
T67083 liver and spleen .h 1104 to 1436 336 to 4   tiling clone,   333/336
(99 %)
0 diff
(100 %id)
H77483 liver and spleen .h 1253 to 1428 176 to 1       176/176
(100 %)
0 diff
(100 %id)
BP272377   .i 1 to 608 5 to 612 exact tiling clone,   612/612
(100 %)
2 diff
(99.7 %id)
AW376909 colon .j 1 to 746 748 to 1 N8* tiling clone,   748/748
(100 %)
6 diff
(99.2 %id)
AW515076 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .j 666 to 903 238 to 1   tiling clone,   238/238
(100 %)
0 diff
(100 %id)
DA497889 brain .k 1 to 576 2 to 577   tiling clone, capped   576/576
(100 %)
6 diff
(99.0 %id)
CN368190 embryonic stem cells, cell lines H1, H7, andH9 .k 11 to 780 8 to 778   tiling clone,   771/778
(99 %)
7 diff
(99.2 %id)
CN368195 embryonic stem cells, cell lines H1, H7, andH9 .k 74 to 766 1 to 694   tiling clone,   694/695
(99 %)
2 diff
(99.8 %id)
AV700856 hepatocellular carcinoma .k 729 to 1440 689 to 1   tiling clone,   689/693
(99 %)
0 diff
(100 %id)
EB388794 eye, optic nerve .l 1 to 725 1 to 725 exact tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 725/725
(100 %)
1 diff
(99.9 %id)
BX418148 brain, fetal brain .l 109 to 998 892 to 1 G3X P12X Q15L K16X S18Y ... tiling clone,   892/892
(100 %)
28 diff
(96.9 %id)
AI969470 malignant melanoma, metastatic to lymphnode, skin .l 109 to 727 621 to 3 P12L Q15K N20K V21L K24R ...     619/623
(99 %)
11 diff
(98.3 %id)
CB243871 Human Lung Epithelial cells, lung .l 109 to 725 635 to 19 exact AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 617/630
(97 %)
0 diff
(100 %id)
BM811001 amelanotic melanoma, cell line, skin .l 118 to 725 1 to 608   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 608/608
(100 %)
2 diff
(99.7 %id)
BU629421 cell lines, Chondrosarcoma .l 123 to 725 621 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 603/603
(100 %)
2 diff
(99.7 %id)
BQ775215 Bone, Human Chondrosarcoma Cell Line .l 130 to 725 614 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 596/600
(99 %)
2 diff
(99.7 %id)
BE044090 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .l 134 to 725 591 to 1       591/591
(100 %)
3 diff
(99.5 %id)
BY995242   .l 145 to 725 644 to 64   AAA Submitted on the opposite strand 581/581
(100 %)
3 diff
(99.5 %id)
BM272666 insulinoma, Pancreas .l 146 to 725 599 to 20   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 580/580
(100 %)
2 diff
(99.7 %id)
AA837311 germinal center B cell .l 161 to 638 479 to 1       479/479
(100 %)
5 diff
(99.0 %id)
CA502867 Human Lung Epithelial cells, lung .l 165 to 725 578 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 560/566
(98 %)
3 diff
(99.5 %id)
DB350577.
matches multiple genes
trachea .l 166 to 725 560 to 1     also hits gene heyoyu 560/560
(100 %)
1 diff
(99.9 %id)
BF939707 brain, glioblastoma (pooled) .l 167 to 723 559 to 3       557/559
(99 %)
10 diff
(98.3 %id)
BP388297 pancreatic islet .l 185 to 703 1 to 520     Submitted on the opposite strand 520/520
(100 %)
1 diff
(99.9 %id)
AA778294 heart .l 191 to 726 536 to 1       536/536
(100 %)
0 diff
(100 %id)
AI951966 brain, four pooled pituitary adenomas .l 194 to 732 552 to 13   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 540/634
(85 %)
10 diff
(98.5 %id)
BG035397 adenocarcinoma, cell line, Liver .l 194 to 725 1 to 532   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 532/532
(100 %)
1 diff
(99.9 %id)
AI334209 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l 212 to 727 521 to 6       516/521
(99 %)
0 diff
(100 %id)
AA568602 colon, colon tumor RER+ .l 218 to 724 507 to 1       507/507
(100 %)
8 diff
(98.5 %id)
AA946837 2 pooled tumors (clear cell type), Kidney .l 222 to 727 505 to 2       504/505
(99 %)
1 diff
(99.9 %id)
BX384744   .l 223 to 727 6 to 510       505/510
(99 %)
6 diff
(98.9 %id)
BQ307562 breast .l 229 to 770 544 to 2       543/544
(99 %)
1 diff
(99.9 %id)
AI150191   .l 239 to 725 497 to 11   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 487/487
(100 %)
1 diff
(99.8 %id)
BG121171 adenocarcinoma, cell line, Liver .l 239 to 721 1 to 491       491/856
(57 %)
11 diff
(98.8 %id)
BJ996748 hepatoblastoma .m 1 to 538 1 to 538 exact tiling clone,   538/538
(100 %)
0 diff
(100 %id)
DB360847.
matches multiple genes
mammary gland .n 1 to 552 551 to 1 V2G S3X E4X L7X T17P ... tiling clone, also hits gene seybobo 551/566
(97 %)
3 diff
(99.5 %id)
BQ307561 breast .n 74 to 594 530 to 10       521/532
(97 %)
3 diff
(99.5 %id)
AI587101 adenocarcinoma, Pancreas .n 74 to 552 504 to 27   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 478/511
(93 %)
14 diff
(97.3 %id)
TI_154096170   .n 74 to 908 903 to 74   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 830/1102
(75 %)
44 diff
(96.1 %id)
C75603   .n 76 to 554 486 to 7       480/508
(94 %)
9 diff
(98.3 %id)
AI281280 adenocarcinoma, colon .n 76 to 554 484 to 5       480/517
(92 %)
3 diff
(99.5 %id)
AI198839   .n 82 to 552 485 to 17   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 469/473
(99 %)
1 diff
(99.8 %id)
AA236574 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .n 83 to 553 471 to 1       471/471
(100 %)
2 diff
(99.6 %id)
AI139373 uterus .n 83 to 553 470 to 1       470/470
(100 %)
1 diff
(99.8 %id)
AA789258   .n 85 to 554 472 to 3       470/473
(99 %)
4 diff
(99.2 %id)
AI127770 uterus .n 85 to 554 471 to 2       470/471
(99 %)
0 diff
(100 %id)
DB516539 testis .n 92 to 550 1 to 458     Submitted on the opposite strand 458/459
(99 %)
4 diff
(99.2 %id)
AI140786 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .n 93 to 552 460 to 1       460/460
(100 %)
2 diff
(99.6 %id)
AI187231   .n 96 to 552 463 to 11   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 453/453
(100 %)
6 diff
(98.7 %id)
AI025112 breast .n 100 to 396 297 to 1       297/298
(99 %)
31 diff
(89.6 %id)
AI754062 bone marrow stroma .n 110 to 552 461 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 443/443
(100 %)
1 diff
(99.8 %id)
AI753243 bone marrow stroma .n 112 to 552 462 to 22   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 441/441
(100 %)
0 diff
(100 %id)
AA236620 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .n 117 to 213 1 to 97   fully sequenced,   97/97
(100 %)
0 diff
(100 %id)
DV459955 cochlea, ear .n 125 to 372 248 to 1     Submitted on the opposite strand 248/248
(100 %)
0 diff
(100 %id)
AW439362 serous papillary carcinoma, high grade, 2pooled tumors, uterus .n 126 to 552 438 to 12   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 427/427
(100 %)
2 diff
(99.6 %id)
BE395097 endometrium, adenocarcinoma cell line, uterus .n 128 to 554 1 to 428       428/619
(69 %)
6 diff
(99.1 %id)
C17463 placenta .n 129 to 552 1 to 423       423/423
(100 %)
10 diff
(97.7 %id)
DB529805 hippocampus .n 133 to 550 13 to 424     Submitted on the opposite strand 412/425
(96 %)
15 diff
(96.5 %id)
AA227539 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .n 135 to 552 418 to 1       418/418
(100 %)
1 diff
(99.8 %id)
AI400951 Prostate .n 136 to 554 448 to 30       419/449
(93 %)
6 diff
(98.7 %id)
BU571105 brain, glioblastoma .n 136 to 559 1 to 424       424/450
(94 %)
10 diff
(97.8 %id)
R89384 liver and spleen .n 141 to 520 381 to 1       381/383
(99 %)
6 diff
(98.5 %id)
AA872668 pooled germ cell tumors .n 141 to 552 413 to 1       413/413
(100 %)
1 diff
(99.8 %id)
AI344110 colon, colon tumor, RER+ .n 142 to 554 413 to 1       413/413
(100 %)
0 diff
(100 %id)
BG939517 bone marrow stroma .n 149 to 551 450 to 48   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 403/403
(100 %)
12 diff
(97.1 %id)
C05669   .n 162 to 554 401 to 7       395/401
(98 %)
3 diff
(99.3 %id)
AI826398 lymph node, lymphoma, follicular mixed small and largecell .n 165 to 552 388 to 1       388/388
(100 %)
6 diff
(98.5 %id)
CA429080 Cell Line, Chondrosarcoma .n 165 to 552 407 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 389/389
(100 %)
4 diff
(99.0 %id)
AA937248 bowel (skin primary), metastatic melanoma to bowel .n 168 to 399 232 to 1       230/232
(99 %)
17 diff
(92.7 %id)
T17222   .n 168 to 553 387 to 2       386/387
(99 %)
0 diff
(100 %id)
U90736   .n 173 to 351 190 to 11       180/191
(94 %)
0 diff
(100 %id)
BI856959 breast, mammary adenocarcinoma, cell line .n 177 to 552 12 to 387   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 376/387
(97 %)
7 diff
(98.2 %id)
TI_57187745   .n 177 to 552 67 to 442   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 376/387
(97 %)
7 diff
(98.2 %id)
AA236997 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .n 183 to 552 370 to 1   fully sequenced,   370/370
(100 %)
1 diff
(99.8 %id)
BP432532   .n 183 to 545 1 to 363       363/363
(100 %)
4 diff
(98.9 %id)
AI572235 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .n 184 to 552 370 to 1       370/377
(98 %)
13 diff
(96.6 %id)
AW139044   .n 186 to 559 391 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 374/377
(99 %)
5 diff
(98.7 %id)
BE094097 breast .n 187 to 530 29 to 375       347/385
(90 %)
13 diff
(96.7 %id)
AI271344 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .n 187 to 554 369 to 2       368/369
(99 %)
0 diff
(100 %id)
T16445   .n 190 to 553 366 to 2       365/366
(99 %)
2 diff
(99.5 %id)
C75565   .n 198 to 554 363 to 7       357/363
(98 %)
0 diff
(100 %id)
BG391098 embryonal carcinoma, cell line, testis .n 198 to 552 1 to 356   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 356/356
(100 %)
1 diff
(99.8 %id)
CX787662 human embryonic stem cells .n 199 to 913 739 to 25   AAA Submitted on the opposite strand 715/715
(100 %)
2 diff
(99.8 %id)
R42323 whole brain .n 206 to 553 370 to 10       359/370
(97 %)
8 diff
(97.9 %id)
BU535778 mixed (pool of 40 RNAs) .n 215 to 552 1 to 338   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 338/338
(100 %)
1 diff
(99.8 %id)
AI025443   .n 218 to 554 339 to 3       337/345
(97 %)
0 diff
(100 %id)
BI834485 pooled pancreas and spleen .n 219 to 555 1 to 339       339/374
(90 %)
6 diff
(98.4 %id)
TI_57164122   .n 219 to 555 61 to 399       339/1412
(24 %)
12 diff
(99.2 %id)
BF349445 head_neck .n 220 to 336 117 to 1       117/117
(100 %)
2 diff
(98.3 %id)
BF222253 Prostate .n 226 to 559 334 to 1       334/334
(100 %)
1 diff
(99.8 %id)
GD137178   .n 228 to 552 1 to 325   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 325/325
(100 %)
4 diff
(98.8 %id)
GD138344   .n 228 to 552 1 to 325   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 325/325
(100 %)
3 diff
(99.1 %id)
BU536634 mixed (pool of 40 RNAs) .n 229 to 554 1 to 326       326/361
(90 %)
7 diff
(98.1 %id)
C21496   .n 231 to 536 1 to 306       306/308
(99 %)
2 diff
(99.4 %id)
BY999590   .n 231 to 554 1 to 324     Submitted on the opposite strand 324/325
(99 %)
2 diff
(99.4 %id)
BM702683 eye, Retina Foveal and Macular .n 252 to 546 1 to 295       295/295
(100 %)
0 diff
(100 %id)
AW303874 serous papillary carcinoma, high grade, 2pooled tumors, uterus .n 253 to 908 653 to 1       653/654
(99 %)
5 diff
(99.3 %id)
BI056616 placenta_normal .n 254 to 688 434 to 1       434/447
(97 %)
6 diff
(98.7 %id)
T35523 lung .n 257 to 550 295 to 1     Submitted on the opposite strand 295/296
(99 %)
2 diff
(99.4 %id)
Z21083   .n 258 to 466 209 to 1       209/209
(100 %)
0 diff
(100 %id)
T39127   .n 262 to 485 224 to 1       224/224
(100 %)
1 diff
(99.6 %id)
DB540730 hippocampus .n 263 to 912 1 to 650   tiling clone, Submitted on the opposite strand 650/650
(100 %)
0 diff
(100 %id)
AA989472 breast .n 263 to 551 289 to 1       289/289
(100 %)
1 diff
(99.7 %id)
AA528463 Kidney .n 269 to 465 197 to 1       197/205
(96 %)
0 diff
(100 %id)
TI_151765116   .n 272 to 920 81 to 730   tiling clone,   650/1102
(58 %)
11 diff
(99.1 %id)
DW426316 Liver .n 293 to 550 17 to 274       258/282
(91 %)
8 diff
(97.2 %id)
FN075464 breast carcinoma .n 303 to 389 1 to 87       87/87
(100 %)
0 diff
(100 %id)
BU564927 mixed (pool of 40 RNAs) .n 313 to 549 1 to 237   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 237/237
(100 %)
0 diff
(100 %id)
DA266598 caudate nucleus .o 1 to 558 2 to 560 L11P T12N E13R Y14I L15F ... tiling clone, capped   559/559
(100 %)
1 diff
(99.9 %id)
DB217639 trachea .o 5 to 537 2 to 534 exact capped   533/533
(100 %)
2 diff
(99.7 %id)
DA531667 brain .o 6 to 610 2 to 606 exact tiling clone, capped   605/605
(100 %)
1 diff
(99.9 %id)
DA758353   .p 1 to 551 2 to 552 exact tiling clone, capped   551/551
(100 %)
0 diff
(100 %id)
AA865982 pooled germ cell tumors .q 1 to 417 417 to 1 exact tiling clone,   417/417
(100 %)
0 diff
(100 %id)
CN368166 embryonic stem cells, DMSO-treated H9 cellline .r 1 to 332 1 to 332   tiling clone,   332/332
(100 %)
1 diff
(99.7 %id)
BG200411   .r 53 to 321 1 to 272       272/272
(100 %)
15 diff
(94.5 %id)
AW609294 stomach .r 143 to 735 599 to 3 M4I L6S E7G K8Q I9N ...     597/606
(98 %)
17 diff
(97.2 %id)
BF375101 stomach .r 143 to 733 593 to 3 I9L I10L I11F P12L E13Q ... tiling clone,   591/612
(96 %)
14 diff
(97.8 %id)
AW813453 stomach .r 153 to 734 601 to 15       587/601
(97 %)
19 diff
(96.9 %id)
BF375112 stomach .r 177 to 733 569 to 15       555/571
(97 %)
10 diff
(98.3 %id)
AW582067 stomach .r 185 to 732 558 to 9       550/559
(98 %)
24 diff
(95.8 %id)
AW813471 stomach .r 202 to 733 536 to 4   tiling clone,   533/536
(99 %)
7 diff
(98.7 %id)
BF375089 stomach .r 249 to 733 498 to 14   tiling clone,   485/501
(96 %)
7 diff
(98.7 %id)
AW609423 stomach .r 268 to 735 495 to 24       472/495
(95 %)
9 diff
(98.2 %id)
AW582082 stomach .r 283 to 730 471 to 17       455/473
(96 %)
15 diff
(96.9 %id)
AW582052 stomach .r 415 to 733 319 to 3       317/319
(99 %)
13 diff
(96.0 %id)
CD641088 pooled .r 477 to 784 1 to 308   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 308/308
(100 %)
2 diff
(99.4 %id)
BE927936 colon .t-u 1 to 638 4 to 642 S25R tiling clone,   639/645
(99 %)
16 diff
(97.6 %id)
AW385433 leiomios .t-u 368 to 587 237 to 18 G43D tiling clone,   220/237
(92 %)
0 diff
(100 %id)
DA121468 cerebellum .u 1 to 528 2 to 530   tiling clone, capped   529/529
(100 %)
2 diff
(99.7 %id)
DB215103 trachea .u 6 to 545 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DA405002 thalamus .u 17 to 552 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
DB215133 trachea .u 17 to 563 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA644271   .u 18 to 581 2 to 565   tiling clone, capped   564/564
(100 %)
0 diff
(100 %id)
DB243595 stomach, tumor tissue .u 21 to 587 2 to 568 exact tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
BM706309 eye, lens .va-u 1 to 471 1 to 471 exact tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 471/471
(100 %)
1 diff
(99.8 %id)
DW411259 Liver .vb-u 1 to 321 330 to 11 K21R L38F L39* tiling clone,   320/330
(96 %)
0 diff
(100 %id)
DW423291 Liver .vc-u 1 to 283 10 to 292 Y2G tiling clone,   283/292
(96 %)
6 diff
(98.0 %id)
BF827962 head_normal .vd 1 to 166 167 to 2 S6R tiling clone, Submitted on the opposite strand 166/167
(99 %)
5 diff
(97.1 %id)
AK297270 brain Gene CSE1L, variant not shown         Suspected internal deletion, this clone was ignored    
AK297314 brain Gene CSE1L, variant not shown         Suspected internal deletion, this clone was ignored    
AK298477   Gene CSE1L, variant not shown         Suspected internal deletion, this clone was ignored    
AK299549 brain Gene CSE1L, variant not shown         Suspected internal deletion, this clone was ignored    
AK307965 brain Gene CSE1L, variant not shown         Suspected internal deletion, this clone was ignored    
BF361281 pnet Gene CSE1L, variant not shown         This clone was ignored    
BQ333364 pnet Gene CSE1L, variant not shown         This clone was ignored    
DC350501 brain Gene CSE1L, variant not shown         Suspected internal deletion, this clone was ignored    
DC350622 brain Gene CSE1L, variant not shown         Suspected internal deletion, this clone was ignored    
DC355557   Gene CSE1L, variant not shown         This clone was ignored    
AA504198 germinal center B cell Gene CSE1L, variant not shown              
AA504432 germinal center B cell Gene CSE1L, variant not shown              
BG494093 lung, mucoepidermoid carcinoma Gene CSE1L, variant not shown              
DC374374 brain Gene CSE1L, variant not shown         This clone was ignored    
DC374618 brain Gene CSE1L, variant not shown         Suspected internal deletion, this clone was ignored    
TI_154030365   Gene CSE1L, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s-u, .t-u, .u, .va-u, .vb-u, .vc-u, .vd Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI